Cyanotech (OTCMKTS:CYAN) Announces Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) released its earnings results on Tuesday. The biotechnology company reported $0.12 EPS for the quarter, Zacks reports. The firm had revenue of $7.96 million during the quarter. Cyanotech had a negative net margin of 0.25% and a negative return on equity of 0.86%.

Cyanotech Price Performance

Shares of CYAN stock remained flat at $0.54 during mid-day trading on Thursday. The stock had a trading volume of 49,624 shares, compared to its average volume of 2,121. Cyanotech has a 1-year low of $0.23 and a 1-year high of $0.78. The company has a fifty day simple moving average of $0.53 and a 200-day simple moving average of $0.46. The company has a current ratio of 1.06, a quick ratio of 0.39 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $4.14 million, a PE ratio of -2.16 and a beta of -0.09.

Cyanotech Company Profile

Cyanotech Corporation is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products. Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis . Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.